The global human fibrinogen concentrates market is expanding steadily, with a projected valuation of USD 1.33 billion in 2025 and an expected growth to approximately …
The global lyophilized oncology drug market is poised for substantial growth, fueled by rising cancer incidence and increasing adoption of biologic therapies that require enhanced …
The global neoantigen cancer vaccine market was valued at USD 475.68 million in 2025 and is forecasted to escalate impressively to approximately USD 1,799.21 million …
A robust CAGR and growing demand for targeted therapies set stage for transformative growth of bispecific antibody contract development and manufacturing across global markets The …
The global preeclampsia diagnostics market is projected to grow from USD 1.29 billion in 2025 to USD 1.70 billion by 2034, expanding at a CAGR …
The global checkpoint inhibitor biologics CDMO market is projected to see remarkable growth from 2025 to 2034, driven by rising oncology pipelines, technological advances, and …
The global RNA interference (RNAi) drug delivery market, valued at USD 118.18 billion in 2025, is on a remarkable growth trajectory expected to reach approximately …
The global exosome-based cancer therapy contract development and manufacturing organization (CDMO) market is witnessing rapid growth, propelled by advancements in exosome technology, rising cancer prevalence, …
The global cell encapsulation technology market is projected to grow significantly, driven by advances in biocompatible materials, immunoprotective systems, and AI-enabled research. Valued strongly today, …
The cell and gene therapy quality control and analytics market stands at the forefront of the next healthcare revolution. Growing at a remarkable compound annual …
by